InvestorsHub Logo
Followers 11
Posts 259
Boards Moderated 0
Alias Born 03/01/2024

Re: fly_fisherman post# 45121

Wednesday, 04/03/2024 9:55:23 AM

Wednesday, April 03, 2024 9:55:23 AM

Post# of 48397
Yeah, it would only be logical that a drug candidate that has progressed extremely positively in the NIH preclinicals would already have engagement with big pharma. Purpose of the new hire 4 months ago? Assumption is they are in tier 3 preclinicals now with NIH, no timeline given to complete, but CEO mentioned loosinenig "pursestrings" in the short term. Really it could happen any day, I suppose. One would think all parties including NIH would want to see success rolled immediately into or ASAP into human clinical trials.

I can only assume the OSA program is underway with preclinical trials as well, but no update there for quite some time.

This is the OTC, so speculative money only, but personally I love the risk v. reward potential here. GLTA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RSPI News